Frank Rimerman Advisors’s Colgate-Palmolive CL Stock Holding History

Frank Rimerman Advisors’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.68M	Buy	19,733 +176	+0.9%	+$15.7K	0.11%	149
2025 Q4	$1.55M	Buy	19,557 +13,761	+237%	+$1.08M	0.1%	161
2025 Q3	$463K	Sell	5,796 -2,666	-32%	-$227K	0.03%	387
2025 Q2	$769K	Buy	8,462 +1,947	+30%	+$178K	0.05%	257
2025 Q1	$610K	Buy	6,515 +700	+12%	+$62.7K	0.05%	279
2024 Q4	$529K	Sell	5,815 -43	-0.7%	-$4.1K	0.04%	297
2024 Q3	$608K	Sell	5,858 -69	-1%	-$7.03K	0.04%	294
2024 Q2	$575K	Buy	5,927 +5,833	+6,205%	+$538K	0.04%	311
2024 Q1	$8.46K	Hold	94	–	–	﹤0.01%	181
2023 Q4	$7.49K	Buy	+94	New	+$7.07K	﹤0.01%	180

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Frank Rimerman Advisors's CL Position: Q1 2026 in Review

Frank Rimerman Advisors increased its Colgate-Palmolive (CL) stake by 0.9% in Q1 2026, buying an estimated $15.7K and bringing the position to 19,733 shares worth $1.68M. The position accounts for 0.11% of the portfolio, ranked #149.

Frank Rimerman Advisors first reported a position in CL in Q4 2023 and has held it in 10 quarters since. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Frank Rimerman Advisors held 19,733 shares of Colgate-Palmolive worth $1.68M as of Q1 2026.
Frank Rimerman Advisors bought 176 Colgate-Palmolive shares in Q1 2026, an estimated $15.7K.
Colgate-Palmolive made up 0.11% of Frank Rimerman Advisors's portfolio in Q1 2026, its #149 holding.
Frank Rimerman Advisors first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 10 quarters since.
1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Frank Rimerman Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.